Authorized purpose: Salix Coronary Plaque (V1.0.0) is a web-based adjunctive tool for qualified cardiologists and radiologists to quantify and characterize coronary plaque and stenosis and perform calcium scoring from adult cardiac CT DICOM images.
Clinical role
Post-processing and quantitative coronary plaque, stenosis, and calcium assessment to support physician review of cardiac CT findings.
Images and patients
CT/CTA · Heart/Cardiovascular
Key limitation
Keep in mind: The software is adjunctive and interpolated views may appear normal for lesions at or below image resolution. Automated outputs and interpolated views require qualified clinical review; the FDA evidence is regulatory technical validation rather than independent clinical-outcome evidence.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Salix Coronary Plaque (V1.0.0) is a web-based adjunctive tool for qualified cardiologists and radiologists to quantify and characterize coronary plaque and stenosis and perform calcium scoring from adult cardiac CT DICOM images.
Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Heart/Cardiovascular Input: Adult CCTA or non-contrast calcium-scoring cardiac CT DICOM images acquired on a CT scanner.
Who uses it?Intended users: Qualified cardiologists and radiologists reviewing adult cardiac CT; the software is an adjunct and does not replace professional judgment.
What does the software produce?Output: Total, calcified, non-calcified, low-density non-calcified, and plaque-burden measurements; CAD-RADS stenosis grade; vessel and lumen profiles; calcium score; vessel centerlines, labels, and segmentations; and a coronary analysis report.
What is its most important limitation?Key limitation: The software is adjunctive and interpolated views may appear normal for lesions at or below image resolution. Automated outputs and interpolated views require qualified clinical review; the FDA evidence is regulatory technical validation rather than independent clinical-outcome evidence.
Clinical takeaway. Clinical role: Salix Coronary Plaque (V1.0.0) is a web-based adjunctive tool for qualified cardiologists and radiologists to quantify and characterize coronary plaque and stenosis and perform calcium scoring from adult cardiac CT DICOM images.
Evidence takeaway. Evidence from the reviewed source record: K251837 FDA evidence is a seven-center regulatory validation of Salix Coronary Plaque V1.0.0 outputs; no independent paper or trial was promoted in this timeboxed review.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Salix Coronary Plaque (V1.0.0) is a web-based adjunctive tool for qualified cardiologists and radiologists to quantify and characterize coronary plaque and stenosis and perform calcium scoring from adult cardiac CT DICOM images.
The software is adjunctive and interpolated views may appear normal for lesions at or below image resolution. Automated outputs and interpolated views require qualified clinical review; the FDA evidence is regulatory technical validation rather than independent clinical-outcome evidence.
K251837 FDA evidence is a seven-center regulatory validation of Salix Coronary Plaque V1.0.0 outputs; no independent paper or trial was promoted in this timeboxed review.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
K251837 FDA evidence is a seven-center regulatory validation of Salix Coronary Plaque V1.0.0 outputs; no independent paper or trial was promoted in this timeboxed review.
DesignRetrospective multi-center regulatory validation of coronary plaque, stenosis, calcium, segmentation, and labeling outputs against reference annotations.
Population103 adult patients from seven geographically diverse U.S. centers; 302 non-contrast and 107 contrast series were reported across task-specific analyses.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The wave22 exact-submission recall query returned no native recall record for K251837. This does not establish absence of family, later-version, or adverse-event information.
CMS LCD L39913 v7 and Article A59813 v6 provide conditional service-level policy context for AI-QCT/AI-CPA after completed and interpreted CCTA in WPS Medicare J5/J8 for selected symptomatic chest-pain patients; exact product/version eligibility and individual claim eligibility are not established.
Product family
Checked 2026-09-07
Service-level policy context; exact product/version and individual claim eligibility are not established. This is not a product code assignment, universal Medicare coverage determination, fee, or price.
Medicare / WPS · United States - WPS J5/J8 jurisdictions · Effective 2026-01-01
CMS policy context applies to an eligible CCTA plaque-analysis service in a limited WPS policy scope; it does not assign coverage to K251837 or establish individual claim eligibility.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Adult CCTA or non-contrast calcium-scoring cardiac CT DICOM images acquired on a CT scanner.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The exact submission accepts cardiac CT DICOM images and operates through a secured network server with image storage; site-specific PACS/RIS routing, identifiers, and report delivery require acceptance testing.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The FDA packet describes a web-based application with secured network-server integration and image storage; it does not establish the site hosting topology, retention, availability, or managed-service boundary for the exact release.
Scope: Exact FDA submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Unresolved route: Total, calcified, non-calcified, low-density non-calcified, and plaque-burden measurements; CAD-RADS stenosis grade; vessel and lumen profiles; calcium score; vessel centerlines, labels, and segmentations; and a coronary analysis report.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The FDA packet describes a web-based application with secured network-server integration and image storage; it does not establish the site hosting topology, retention, availability, or managed-service boundary for the exact release.
The exact submission accepts cardiac CT DICOM images and operates through a secured network server with image storage; site-specific PACS/RIS routing, identifiers, and report delivery require acceptance testing.
Use requires qualified cardiologist or radiologist review of plaque, stenosis, calcium, and segmentation outputs; local onboarding should cover image eligibility, editing, interpolated-view limitations, reports, and escalation.
The exact submission describes a web-based application accepting adult cardiac CT DICOM images through secured network-server integration with image storage; validate local PACS routing and identity mapping before use.
Artrya's current Salix indication describes a web-based tool for trained professionals that supports cardiac CT plaque, stenosis, and calcium scoring on CT data from any CT scanner as an adjunct to clinical judgment.
product family · checked 2026-09-07
Current family indication; confirm exact K251837 version, scanner compatibility, hosting, licensing, and local interfaces.
Buyer acceptance should test vessel labeling, centerline and wall segmentation edits, plaque composition outputs, CAD-RADS reporting, non-contrast calcium workflow, and behavior near image-resolution limits.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-07Last searched
24Fields reviewed
12Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The stored PubMed and ClinicalTrials.gov candidate arrays were screened and were empty. No paper or trial was promoted; empty stored arrays do not establish that no external literature or trials exist. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, payer policy, fda device recall, literature index, trial registry, stored candidate metadata, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-07 - Exact FDA submission
No public list price or contract unit for the exact K251837 configuration was established in the reviewed official sources.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not publicly available - checked 2026-09-07 - Exact FDA submission
The reviewed exact packet and Artrya family indication page do not establish current scoped security controls, certification scope, PHI flow, retention, access control, audit, or incident response for K251837.
Authorized purpose: cvi42 Coronary Plaque supports qualified professionals with viewing, post-processing, and qualitative and quantitative evaluation of adult cardiac CT DICOM images to assess the presence and extent of coronary plaques and stenoses in CCTA for CAD or suspected CAD.
Authorized purpose: Careverse CoronaryDoc is a web-based tool for trained medical professionals to view and analyze CCTA CT data for coronary plaques and stenosis, with coronary measurements, visualization, automated plaque and stenosis outputs, and structured reporting for physician review.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.